Get access

Airway epithelium-derived transforming growth factor-β is a regulator of fibroblast proliferation in both fibrotic and normal subjects

Authors

  • K. E. Hostettler,

    1. Pulmonary Cell Research, Department of Research, University Hospital Basel, Basel, Switzerland,
    2. Respiratory Research Group, Department of Pharmacology, University of Sydney, Sydney, NSW, Australia,
    3. Woolcock Institute of Medical Research, University of Sydney, Sydney, NSW, Australia
    Search for more papers by this author
  • M. Roth,

    1. Pulmonary Cell Research, Department of Research, University Hospital Basel, Basel, Switzerland,
    2. Woolcock Institute of Medical Research, University of Sydney, Sydney, NSW, Australia
    Search for more papers by this author
  • J. K. Burgess,

    1. Respiratory Research Group, Department of Pharmacology, University of Sydney, Sydney, NSW, Australia,
    2. Woolcock Institute of Medical Research, University of Sydney, Sydney, NSW, Australia
    Search for more papers by this author
  • M. M. Gencay,

    1. Pulmonary Cell Research, Department of Research, University Hospital Basel, Basel, Switzerland,
    Search for more papers by this author
  • F. Gambazzi,

    1. Division of Thoracic Surgery, University Hospital Basel, Basel, Switzerland
    Search for more papers by this author
  • J. L. Black,

    1. Respiratory Research Group, Department of Pharmacology, University of Sydney, Sydney, NSW, Australia,
    2. Woolcock Institute of Medical Research, University of Sydney, Sydney, NSW, Australia
    Search for more papers by this author
  • M. Tamm,

    1. Pulmonary Cell Research, Department of Research, University Hospital Basel, Basel, Switzerland,
    Search for more papers by this author
  • P. Borger

    1. Pulmonary Cell Research, Department of Research, University Hospital Basel, Basel, Switzerland,
    2. Woolcock Institute of Medical Research, University of Sydney, Sydney, NSW, Australia
    Search for more papers by this author

Correspondence:
Katrin E. Hostettler, Pulmonary Cell Research, Department of Research, Lab 305, University of Basel, Hebelstrasse 20, 4031 Basel, Switzerland.
E-mail: hostettlerk@uhbs.ch

Summary

Background In the healthy lung, airway epithelial cells (AEC) regulate fibroblast proliferation through release of soluble factors, such as prostaglandins and proteins. Fibroproliferative diseases and airway remodelling may result from an inadequate generation of suppressive factors by AEC or the inability of fibroblasts to respond to them appropriately.

Objective The aim of this study was to study the effect of primary human AEC on the proliferation of fibroblasts obtained from healthy and fibrotic lungs in an interactive cell culture model.

Results Conditioned medium (CM) from 14 out of 16 AEC lines significantly inhibited proliferation of normal human lung fibroblasts by 51.2±6.0%. The proliferation of fibroblasts derived from patients with lung fibrosis was equally inhibited by CM of AEC. The inhibitory effect of AEC-CM was completely reversed when fibroblasts were pre-incubated with 2.5 μm indomethacin. Furthermore, primary human AEC, but not fibroblasts, secrete TGF-β, and the inhibitory effect of the AEC-CM was blocked by neutralizing anti-TGF-β antibodies.

Conclusion These results demonstrate that AEC actively inhibit the proliferation of both normal and fibrotic fibroblasts via TGF-β, which induces the prostaglandin E2 synthesis in fibroblasts. The data indicate that proliferative lung diseases may be treated using the epithelial cell as the target of medication.

Ancillary